Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB diagnosis news


From To
GeneXpert use still hobbled by high pricing, Treatment Action Group, TB Community Advisory Board say

Letter to Cepheid cites continued cost of machines, Russia, China cartridge costs of five to six times negotiated price, and more.

28 January 2014
Science Speaks
GLOBAL: Xpert MTB/RIF Test Quickly Detects TB and Resistance to Rifampicin reported on a second systematic review of the Xpert® MTB/RIF TB test, which is endorsed by the World Health Organization (WHO). WHO commissioned this updated Cochrane Review as part of the process to update the policy on the use of the test.

23 January 2014
CDC National Prevention Information Network
Cotrimoxazole prophylaxis neither reduces TB risk nor complicates TB diagnosis in people with HIV

Cotrimoxazole prophylaxis has no impact on incidence or detection of tuberculosis (TB) in people with HIV, a study published PLoS One shows. The prospective, observational study involved

21 January 2014
Michael Carter
Urgency Needed in the Global Response to Drug-resistant Tuberculosis

In the second of two linked posts, Lindsay McKenna and Colleen Daniels of Treatment Action Group (TAG) describe the importance of access to timely diagnosis and appropriate treatment for patients with drug-resistant tuberculosis and demand that urgency be returned to the global DR-TB response.

04 November 2013
PLoS Blogs
Pros and cons of high-tech TB testing

A new, sophisticated diagnostic test for tuberculosis now being rolled out promises to be faster and more accurate than the old methods and much easier to use. But the first trials of the GeneXpert MTB/RIF Assay test in real-life situations have proved that while all this is true, it did not make any significant difference to treatment outcomes.

30 October 2013
Gains in tuberculosis control at risk due to 3 million missed patients and drug resistance

Tuberculosis (TB) treatment has saved the lives of more than 22 million people, according to the WHO "Global tuberculosis report 2013" published today. The report also reveals that the number of people ill with TB fell in 2012 to 8.6 million, with global TB deaths also decreasing to 1.3 million.

23 October 2013
World Health Organization (press release)
London, tuberculosis capital of Western Europe, uses van with X-ray machine to detect TB

London may be famed for its historic sites, double-decker buses and West End shows, but it now has a more dubious distinction: It has become the tuberculosis capital of Western Europe.In response, health officials are taking to the streets in an effort to stop the spread of the infectious lung disease, with a high-tech white van equipped with an X-ray machine that drives around London offering free check-ups.

23 October 2013
Washington Post
Public Health England plans national primary care TB screening programme

Public health officials are planning a nationally co-ordinated programme of targeted TB screening in primary care, to combat rising infection rates in some urban areas of England. Experts at Public Health England (PHE) claim the best way to ‘reverse the tide’ is for GP practices to start screening for latent TB in at-risk groups, particularly immigrants from areas with a high incidence of the disease.

18 October 2013
A Rapid, Paper-Based Diagnostic Test for Tuberculosis

In a study published in the journal Science and Technology of Advanced Materials (STAM), researchers in Taiwan describe a simple, color-based diagnostic approach with the potential to detect target DNA sequences found in TB-causing mycobacteria -- in just a fraction of the time required for established diagnostic tests.

08 October 2013
Science Daily
First-Ever Targeted Roadmap Outlines Steps to End Childhood TB Deaths

The deaths of more than 74 000 children from tuberculosis (TB) could be prevented each year through measures outlined in the first ever action plan developed specifically on TB and children.

02 October 2013

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.